This week, the U.S. Senate voted (57 to 42) to confirm President Donald Trump’s pick--Scott Gottlieb--as the U.S. Food and Drug Administration’s (FDA’s) new commissioner.
The 44 year old physician has strong ties with the pharmaceutical and biotech industries. However, his association with FDA dates back to the George W. Bush administration when he served as deputy commissioner for medical and scientific affairs.